Estimating Decision-Relevant Comparative Effects Using Instrumental Variables

被引:14
作者
Basu A. [1 ]
机构
[1] Departments of Health Services and Pharmacy, University of Washington, Seattle, Seattle, WA 98195-7660, 1959 NE Pacific St
关键词
Breast cancer; Heterogeneity; Instrumental variables; Local IV methods; Survival;
D O I
10.1007/s12561-011-9033-6
中图分类号
学科分类号
摘要
Instrumental variables methods (IV) are widely used in the health economics literature to adjust for hidden selection biases in observational studies when estimating treatment effects. Less attention has been paid in the applied literature to the proper use of IVs if treatment effects are heterogeneous across subjects. Such a heterogeneity in effects becomes an issue for IV estimators when individuals' self-selected choices of treatments are correlated with expected idiosyncratic gains or losses from treatments. We present an overview of the challenges that arise with IV estimators in the presence of effect heterogeneity and self-selection and compare conventional IV analysis with alternative approaches that use IVs to directly address these challenges. Using a Medicare sample of clinically localized breast cancer patients, we study the impact of breast-conserving surgery and radiation with mastectomy on 3-year survival rates. Our results reveal the traditional IV results may have masked important heterogeneity in treatment effects. In the context of these results, we discuss the advantages and limitations of conventional and alternative IV methods in estimating mean treatment-effect parameters, the role of heterogeneity in comparative effectiveness research and the implications for diffusion of technology. © 2011 International Chinese Statistical Association.
引用
收藏
页码:6 / 27
页数:21
相关论文
共 48 条
[1]  
Amemiya T., The non-linear two-stage least squares estimator, J Econom, pp. 105-110, (1974)
[2]  
Angrist J., Imbens G., Rubin D., Identification of causal effects using instrumental variables, J Am Stat Assoc, 91, pp. 444-455, (1996)
[3]  
Bang H., Robins J.M., Doubly robust estimation in missing data and causal inference models, Biometrics, 61, pp. 962-972, (2005)
[4]  
Basu A., Individualization at the heart of comparative effectiveness research: the time for i-CER has come, Med Decis Mak, 29, 6, pp. 9-11, (2009)
[5]  
Basu A., Heckman J., Navarro-Lozano S., Urzua S., Use of instrumental variables in the presence of heterogeneity and self-selection: an application to treatments of breast cancer patients, Health Econ, 16, 11, pp. 1133-1157, (2007)
[6]  
Basu A., Philipson T., Impact of comparative effectiveness research on health and healthcare spending, (2010)
[7]  
Bjorklund A., Moffitt R., The estimation of wage gains and welfare gains in self-selection, Rev Econ Stat, 69, 1, pp. 42-49, (1987)
[8]  
Blundell R., Powell J., Endogeneity in nonparametric and semiparametric regression models, Advances in Economics and Econometrics, pp. 312-357, (2003)
[9]  
Brooks J.M., Chrischilles E., Scott S., Chen-Hardee S., Was lumpectomy underutilized for early stage breast cancer? Instrumental variables evidence for stage II patients from Iowa, Health Serv Res, 38, 6, pp. 1385-1402, (2003)
[10]  
Earle C.E., Tsai J.S., Gelber R.D., Weinstein M.C., Neumann P.J., Weeks J.C., Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrument variable and propensity analysis, J Clin Oncol, 19, 4, pp. 1064-1070, (2001)